Literature DB >> 24072707

The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.

Joseph Capecci1, Michael Forgac.   

Abstract

The vacuolar H(+) ATPases (V-ATPases) are ATP-driven proton pumps that transport protons across both intracellular and plasma membranes. Previous studies have implicated V-ATPases in the invasiveness of various cancer cell lines. In this study, we evaluated the role of V-ATPases in the invasiveness of two closely matched human breast cancer lines. MCF10a cells are a non-invasive, immortalized breast epithelial cell line, and MCF10CA1a cells are a highly invasive, H-Ras-transformed derivative of MCF10a cells selected for their metastatic potential. Using an in vitro Matrigel assay, MCF10CA1a cells showed a much higher invasion than the parental MCF10a cells. Moreover, this increased invasion was completely sensitive to the specific V-ATPase inhibitor concanamycin. MCF10CA1a cells expressed much higher levels of both a1 and a3 subunit isoforms relative to the parental line. Isoforms of subunit a are responsible for subcellular localization of V-ATPases, with a3 and a4 targeting V-ATPases to the plasma membrane of specialized cells. Knockdown of either a3 alone or a3 and a4 together using isoform-specific siRNAs inhibited invasion by MCF10CA1a cells. Importantly, overexpression of a3 but not the other a subunit isoforms greatly increased the invasiveness of the parental MCF10a cells. Similarly, overexpression of a3 significantly increased expression of V-ATPases at the plasma membrane. These studies suggest that breast tumor cells employ particular a subunit isoforms to target V-ATPases to the plasma membrane, where they function in tumor cell invasion.

Entities:  

Keywords:  Bioenergetics; Breast Cancer; Invasion; Proton Pumps; Proton Transport; Vacuolar ATPase; a Subunit Isoforms

Mesh:

Substances:

Year:  2013        PMID: 24072707      PMCID: PMC3820907          DOI: 10.1074/jbc.M113.503771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Specific sorting of the a1 isoform of the V-H+ATPase a subunit to nerve terminals where it associates with both synaptic vesicles and the presynaptic plasma membrane.

Authors:  Nicolas Morel; Jean-Claude Dedieu; Jean-Marc Philippe
Journal:  J Cell Sci       Date:  2003-12-01       Impact factor: 5.285

2.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

3.  From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation.

Authors:  Takao Toyomura; Yoshiko Murata; Akitsugu Yamamoto; Toshihiko Oka; Ge-Hong Sun-Wada; Yoh Wada; Masamitsu Futai
Journal:  J Biol Chem       Date:  2003-04-02       Impact factor: 5.157

4.  The amino-terminal domain of the vacuolar proton-translocating ATPase a subunit controls targeting and in vivo dissociation, and the carboxyl-terminal domain affects coupling of proton transport and ATP hydrolysis.

Authors:  S Kawasaki-Nishi; K Bowers; T Nishi; M Forgac; T H Stevens
Journal:  J Biol Chem       Date:  2001-10-09       Impact factor: 5.157

5.  Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.

Authors:  S J Santner; P J Dawson; L Tait; H D Soule; J Eliason; A N Mohamed; S R Wolman; G H Heppner; F R Miller
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

6.  Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing.

Authors:  A N Smith; J Skaug; K A Choate; A Nayir; A Bakkaloglu; S Ozen; S A Hulton; S A Sanjad; E A Al-Sabban; R P Lifton; S W Scherer; F E Karet
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Molecular cloning and characterization of Atp6n1b: a novel fourth murine vacuolar H+-ATPase a-subunit gene.

Authors:  A N Smith; K E Finberg; C A Wagner; R P Lifton; M A Devonald; Y Su; F E Karet
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

8.  a4, a unique kidney-specific isoform of mouse vacuolar H+-ATPase subunit a.

Authors:  T Oka; Y Murata; M Namba; T Yoshimizu; T Toyomura; A Yamamoto; G H Sun-Wada; N Hamasaki; Y Wada; M Futai
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

9.  Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation.

Authors:  T Toyomura; T Oka; C Yamaguchi; Y Wada; M Futai
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

10.  Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer.

Authors:  An Hendrix; Raija Sormunen; Wendy Westbroek; Kathleen Lambein; Hannelore Denys; Gwen Sys; Geert Braems; Rudy Van den Broecke; Veronique Cocquyt; Christian Gespach; Marc Bracke; Olivier De Wever
Journal:  Int J Cancer       Date:  2013-03-07       Impact factor: 7.396

View more
  34 in total

1.  Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.

Authors:  Kristina Cotter; Joseph Capecci; Souad Sennoune; Markus Huss; Martin Maier; Raul Martinez-Zaguilan; Michael Forgac
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

Review 2.  Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness.

Authors:  Christina McGuire; Kristina Cotter; Laura Stransky; Michael Forgac
Journal:  Biochim Biophys Acta       Date:  2016-02-22

3.  Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.

Authors:  Christina M McGuire; Michael P Collins; GeHong Sun-Wada; Yoh Wada; Michael Forgac
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

4.  Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.

Authors:  Arpita Kulshrestha; Gajendra K Katara; Jordyn Ginter; Sahithi Pamarthy; Safaa A Ibrahim; Mukesh K Jaiswal; Corina Sandulescu; Ramayee Periakaruppan; James Dolan; Alice Gilman-Sachs; Kenneth D Beaman
Journal:  Mol Oncol       Date:  2016-01-29       Impact factor: 6.603

5.  TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.

Authors:  F Lozupone; M Borghi; F Marzoli; T Azzarito; P Matarrese; E Iessi; G Venturi; S Meschini; A Canitano; R Bona; A Cara; S Fais
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

6.  Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.

Authors:  Larry Fliegel
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 7.  Recent Insights into the Structure, Regulation, and Function of the V-ATPases.

Authors:  Kristina Cotter; Laura Stransky; Christina McGuire; Michael Forgac
Journal:  Trends Biochem Sci       Date:  2015-10       Impact factor: 13.807

Review 8.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

9.  A cation-π interaction in a transmembrane helix of vacuolar ATPase retains the proton-transporting arginine in a hydrophobic environment.

Authors:  Walter Hohlweg; Gabriel E Wagner; Harald F Hofbauer; Florian Sarkleti; Martina Setz; Nina Gubensäk; Sabine Lichtenegger; Salvatore Fabio Falsone; Heimo Wolinski; Simone Kosol; Chris Oostenbrink; Sepp D Kohlwein; Klaus Zangger
Journal:  J Biol Chem       Date:  2018-09-12       Impact factor: 5.157

Review 10.  Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

Authors:  Ebbe Boedtkjer
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.